Shainaba A Saadhali

Shainaba A Saadhali

Auto-generated profile, based on publicly available information

Shainaba A Saadhali

Department of Bacteriology, ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
APAmudha Prabu
Amudha Prabu
SHSameer Hassan
Sameer Hassan
PRPrabuseenivasan
Prabuseenivasan
ASA.S. Shainaba
A.S. Shainaba
LHLuke Elizabeth Hanna
Luke Elizabeth Hanna
VKVanaja Kumar
Vanaja Kumar

13 July 2016 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
SSShainaba A Saadhali
Shainaba A Saadhali
SHSameer Hassan
Sameer Hassan
LHLuke Elizabeth Hanna
Luke Elizabeth Hanna
URUma Devi Ranganathan
Uma Devi Ranganathan
VKVanaja Kumar
Vanaja Kumar

30 September 2025 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
BTBenjamin Isaac Thomson
Benjamin Isaac Thomson
SSShainaba A Saadhali
Shainaba A Saadhali
The use of efflux pump inhibitors (EPIs) as adjuvant therapy to combat bacterial resistance to several antibiotics has been a proven method to fight antimicrobial resistance. Antibiotic- expelling efflux pumps, which are found in bacterial cell membranes, play a major role in the development of multidrug resistance. Therefore, EPIs, which are meant to inhibit these pumps, have the potential to make the current antibiotic arsenal more effective. Here we classify efflux pumps, analyse the many complexities of EPI processes, and emphasize the range of sources and applications. This academic review thus highlights the functioning of efflux pumps, the critical role that efflux pump inhibitors play and advocates for more research into efflux pump inhibitors.